Skip to main content

IHV Lifetime Achievement Award

2023 IHV 25th Anniversary Lifetime Achievement Award for Scientific Contributions and Drug Development

William Haseltine, PhD

William Haseltine, PhD

William Haseltine, PhD, is an American scientist, businessman, author, and philanthropist. He is known for his groundbreaking work on HIV/AIDS, the human genome, and the COVID-19 pandemic. He was a Professor at Harvard Medical School, where he founded two research departments on cancer and HIV/AIDS.

Dr. Haseltine helped create the biotechnology companies ProScript Inc. that developed a treatment multiple myeloma and other cancers, and Dendreon that developed the first approved cell-based cancer therapy for treating metastatic prostate cancer. Haseltine co-founded Human Genome Sciences, which developed a number of drugs for treating diabetes and its complications, cancers, obesity, and anthrax.

After completing the sequence of the HIV genome, Dr. Haseltine's laboratory then showed that damage to certain viral genes killed the virus, identifying good antiviral drugs. The first HIV-specific protease inhibitor, Nelfinavir, was developed as a part of a collaboration between the Haseltine laboratory, Cambridge BioSciences — another company founded by Dr. Haseltine —, and Agouron Pharmaceuticals. He founded additional biotechnology companies including The Virus Research Institute, LeukoSite, Diversa, X-VAX, and Demetrix.

Dr. Haseltine successfully advocated for Congress to HIV/AIDS research through the NIH. He publicly advocated for destigmatizing HIV infection. He played an important early role in creating the International Society for AIDS Research, now the International AIDS Society, and was the Founding Editor of the scientific journal AIDS Research and Human Retroviruses. Dr. Haseltine went on to co-found E-Biomed: The Journal of Regenerative Medicine and The Society for Regenerative Medicine to help expand the field of regenerative medicine.

Committed to philanthropy, Dr. Haseltine founded two non-profit foundations. He is President of the Haseltine Foundation for Science and the Arts, and Chairman and President of ACCESS Health International, an organization dedicated to improving access to high-quality health outcomes worldwide through medical technology. In 2001 he was listed by Time Magazine as one of the world's 25 most influential businesspeople, and in 2015 by Scientific American as one of the 100 most influential leaders in biotechnology. He is the author of more than two hundred peer-reviewed manuscripts and fifteen books.


Past Awardees

Select an award to see a list of recipients from previous years.

Lifetime Achievement Award for Scientific Contributions

Lifetime Achievement Award for Public Service

One-Time Lifetime Achievement Award for Excellence in Teaching

Lifetime Achievement Award for Excellence in Medical Education, Clinical Care, and Clinical Research

Lifetime Achievement Award for Excellence in Clinical Research

×